Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Magforce AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

MagForce AG (MF6) - Financial Analysis Review

MagForce AG (MF6) - Financial Analysis Review Summary MagForce AG (MagForce) is a healthcare service provider that offers nan...

19 Apr 2016 GlobalData 46 $300.00

MagForce AG (MF6) - Financial Analysis Review

MagForce AG (MF6) - Financial Analysis Review Summary MagForce AG (MagForce) is a healthcare service provider that offers nan...

15 Mar 2016 GlobalData 48 $300.00

MagForce AG (MF6) - Financial Analysis Review

MagForce AG (MF6) - Financial Analysis Review Summary MagForce AG (MagForce) is a healthcare service provider that offers nan...

16 Dec 2015 GlobalData 49 $300.00

MAGFORCE AG - ON THE PATH TO THE US; FIRST SALES IN EUROPE

During 2015, MagForce has made progress in both the US and Europe with its NanoTherm nanoparticle-based therapy for cancer. F...

09 Nov 2015 Edison Investment Research 2 $10.00

MagForce AG (MF6) - Financial Analysis Review

MagForce AG (MF6) - Financial Analysis Review Summary MagForce AG (MagForce) is a healthcare service provider that offe...

29 Jul 2015 GlobalData 41 $125.00

MAGFORCE - DELIVERING THE GOODS

MagForce continues to deliver on its multi-pronged strategy to drive uptake and acceptance of its NanoTherm nanoparticle-base...

09 Feb 2015 Edison Investment Research 4 $10.00

MAGFORCE - DEUTSCHES EIGENKAPITALFORUM

MagForce continues to advance towards driving uptake and acceptance of its NanoTherm nanoparticle-based treatment for cancer....

28 Jan 2015 Edison Investment Research 2 $10.00

MAGFORCE - FIRMING UP FUNDS FOR NANOTHERM

A €10m capital increase removes a potential funding requirement in 2015, allowing MagForce to focus on its strategy to drive ...

02 Dec 2014 Edison Investment Research 4 $10.00

MAGFORCE - ACCELERATING ON THE US HIGHWAY

Progress made in the US and clarity around the regulatory requirements for NanoTherm therapy in both GBM and prostate cancer ...

09 Sep 2014 Edison Investment Research 12 $10.00